Why BeOne Medicines AG’s (ONC) Stock Is Up 5.19%
As of Friday, November 06, BeOne Medicines AG’s ONC share price has surged by 5.19%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Tudor Pop
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
| Share Statistics | ONC | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $47,579.7 | $211.8 | 93% |
|
| Shares Out (Mil) | 117.3 | 55.4 | 65% |
|
| Institutional Ownership | 93.0% | 93.0% | 62% |
|
| Float (Mil) | 81.4 | 41.5 | 56% |
|
| Beta | 0.63 | 0.99 | 36% |
|
| Avg Daily Volume (000s) | 553 | 553 | 58% |
|
| Price Change (52-week) |
10.4% | 42.8% | 60% |
|
| Growth | ONC | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 76.8% | 13.2% | 98% |
|
| Net Income (5yr) | 16.8% | (10.3%) | 67% |
|
| EPS (5yr) | 16.3% | 15.8% | 60 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 14.4% | (15.7%) | 72% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 9 | 13 | 17 | |
| Current EPS | $2.634 | $9.872 | $10.719 | |
| Month Ago EPS | $1.554 | $7.641 | $10.252 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $1.530 | $7.598 | $10.284 | |
| Year/Year Chg | (19.0%) | 299.7% | 439.5% | |
| Financials | ONC | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $6,607 | $41 | 78% |
|
| Net Income (TTM) (Mil) | $916 | ($44) | 85% |
|
| EPS (TTM) | $8.193 | ($1.500) | 92% |
|
| Operating Cash Flow (TTM) (Mil) | $1,590 | ($35) | 85% |
|
| Net Cash Flow (TTM) (Mil) | $1,756 | $-0 | 96% |
|
| Long-Term Debt (Q1) (Mil) | $1,682 | $4 | 72% |
|
| Enterprise Value (Q1) (Mil) | $43,950 | $147 | 91% |
|
| Valuation | ONC | Industry Median |
Percentile (All Stocks) |
|
| P/B | 8.17 | 2.01 | 89% |
|
| P/E | 53.3 | 17.9 | 87% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 3.3 | 1.0 | 81% |
|
| Ratios | ONC | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 89.4% | 67.9% | 93% |
|
| Net Margin | 13.9% | (50.6%) | 70% |
|
| ROA | 10.5% | (47.4%) | 88% |
|
| ROE | 18.4% | (53.1%) | 77% |
|
| Liabilities to Assets | 41.1% | 29.7% | 32% |
|
| F-Score | 7 | 3 | na |
|
Passing Stock Screens
As of 11/13/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 21.3% |
| +/- S&P 500: | +13.9 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors